This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Laimu Corporation. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Akihiro Tai: Innovator in Neurogenesis and Nerve Growth
Introduction
Akihiro Tai is a prominent inventor based in Shobara, Japan. He has made significant contributions to the field of neurogenesis and nerve growth, holding a total of 5 patents. His work focuses on developing innovative solutions that promote nerve growth and enhance cellular functions.
Latest Patents
Tai's latest patents include a neurogenesis stimulant, which is an internal agent designed to enhance the growth of nerve cells. He has also developed a culture medium additive and a cell diluent additive that support cellular growth and maintenance. Another notable patent involves a nerve growth promoter and a method for producing the same, which includes an antioxidant and a wound treatment agent derived from a degradation product of hyaluronic acid and protein. These inventions reflect his commitment to advancing medical science and improving therapeutic outcomes.
Career Highlights
Throughout his career, Akihiro Tai has been associated with Laimu Corporation, where he has been instrumental in driving research and development initiatives. His innovative approach has led to breakthroughs in the understanding of neurogenesis and its applications in medicine. Tai's work is characterized by a blend of scientific rigor and practical application, making him a valuable asset in his field.
Collaborations
Tai has collaborated with notable colleagues such as Sachio Wakayama and Takeru Koga. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.
Conclusion
Akihiro Tai's contributions to the field of neurogenesis and nerve growth are noteworthy. His innovative patents and collaborative efforts position him as a leading figure in medical research. His work continues to inspire advancements in therapeutic solutions for nerve-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile